Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05786924
Title A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Black Diamond Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner Health- MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
University of Colorado - Aurora Cancer Center Aurora Colorado 80045 United States Details
Georgetown University Lombardi Cancer Center Washington District of Columbia 20007 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids Michigan 49546 United States Details
Masonic Cancer Center University of Minnesota Minneapolis Minnesota 55455 United States Details
Washington University Saint Louis Missouri 63130 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
UNC Hospitals, The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 United States Details
Huntsman Cancer Institute (University of Utah) Salt Lake City Utah 84112 United States Details
NEXT Virginia Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field